When APC and CTNNB1 mutations were compared, there was evidence for selection of CTNNB1 mutations over common APC mutations in each of liver cancer, uterine carcinoma, prostate cancer and colorectal cancer (Fig. 5a–c Supplementary Fig. 19). Here, APC is linked to prostate carcinoma.